Xing et al. observed that circRAD18 facilitates cell proliferation and glycolysis through the upregulation of HK2 by sponging miR-613, indicating that circRAD18 could be valuable a therapeutic target for BC treatment [53]. Here, HK2 is linked to breast cancer.